Preparing for the next viral threat with broad-spectrum antivirals
Journal of Clinical Investigation · 01.06.2023 · 133 (11)
DOI: 10.1172/jci170236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.06.2023. Verfasst von Marwah Karim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, and. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Viruses. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
There is a large global unmet need for the development of countermeasures to combat hundreds of viruses known to cause human disease and for the establishment of a therapeutic portfolio for future pandemic preparedness. Most approved antiviral therapeutics target proteins encoded by a single virus, providing a narrow spectrum of coverage. This, combined with the slow pace and high cost of drug development, limits the scalability of this direct-acting antiviral (DAA) approach. Here, we summarize progress and challenges in the development of broad-spectrum antivirals that target either viral elements (proteins, genome structures, and lipid envelopes) or cellular proviral factors co-opted by multiple viruses via newly discovered compounds or repurposing of approved drugs. These strategies offer new means for developing therapeutics against both existing and emerging viral threats that complement DAAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, and.
- Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
- Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA.
Förderung
- NIAID NIH HHS
Zitieren
APA
Karim, M., Lo, C. W., & Einav, S. (2023). Preparing for the next viral threat with broad-spectrum antivirals. Journal of Clinical Investigation, 133(11). https://doi.org/10.1172/jci170236
Vancouver
Karim M, Lo CW, Einav S. Preparing for the next viral threat with broad-spectrum antivirals. Journal of Clinical Investigation. 2023;133(11). doi:10.1172/jci170236
BibTeX
@article{Karim2023,
author = {Karim, Marwah and Lo, Chieh-Wen and Einav, Shirit},
title = {Preparing for the next viral threat with broad-spectrum antivirals},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {11},
doi = {10.1172/jci170236}
}
EUVIMED